18 research outputs found

    Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

    Get PDF
    Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Avaliação e caracterização da qualidade da carne de peito (Pectoralis major) de matrizes pesadas em final de ciclo produtivo

    No full text
    Este trabalho teve por objetivo avaliar as características da qualidade da carne de matrizes pesadas de descarte. Para isto, foram coletadas 40 amostras de filés de peito (Pectoralis major) de matrizes da linhagem Ross com 68 e 69 semanas de idade. As coletas foram divididas em duas, com 20 amostras coletadas em cada uma delas. No tempo zero (após o resfriamento) foi medido o pH e coletados fragmentos para a avaliação do valor R. Nos tempos 4 e 24 horas post-mortem, foram feitas as seguintes análises: pH, valor R, cor objetiva, perda por exsudação (drip loss), capacidade de retenção de água (CRA), capacidade de absorção de água (CAA), perdas de peso por cozimento (PPC) e força de cisalhamento (FC). Houve diferença (p < 0,05) para os valores médios de pH entre os tempos zero (após o resfriamento), 4 e 24 horas que foram de 6,49; 5,78; e 5,65, respectivamente. O resultado médio encontrado para CRA foi de 26,45. Para a cor objetiva, os resultados médios para o L*, a* e b* foram de 52,20; 3,64; 0,51, respectivamente. Portanto, conclui-se que, quando observados os resultados das análises para os parâmetros perda por exsudato, perda de peso por cozimento e capacidade de absorção de água, a carne de peito das matrizes pesadas apresenta ótima qualidade tecnológica apesar de apresentar problemas na sua textura.The objective of this study was to evaluate the meat quality characteristics in broiler breeder hen. For this purpose, 40 breast fillet samples (Pectoralis major) of breeder hen, Ross strain with 68 and 69 weeks of age, were collected. The samples were collected twice, and each time twenty samples were obtained. At zero time, (after chilling time) the pH was measured and fragmented samples were collected to evaluate the R value it. At 4 and 24 hours post-mortem, the following analyses were performed: pH, R-value, color, drip loss, water holding capacity (WHC), water absorption capacity (WAC), cooking loss, and shear force. There was a significant difference (p < 0.05) in the average pH values in the zero time (after chilling), 4, and 24 hours, 6.49; 5.78, and 5.65, respectively. The average value of WHC was 26.45. With respect to the objective color, the average values obtained for L*, a*, and b* were 52.20; 3.64; 0.51; respectively. Therefore, it can be concluded that the results obtained for drip loss, cooking loss, and water absorption capacity indicate that the breast meat of breeder hens presented very good technological quality despite its texture problems

    Ser e tornar-se professor: práticas educativas no contexto escolar

    No full text

    Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    No full text
    Backgroun

    International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

    No full text
    Background Atrial fibrillation (AF) is the most common cardiac arrhythmia in the world. We aimed to provide comprehensive data on international patterns of AF stroke prevention treatment

    Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    No full text
    Introduction A principal aim of the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) was to document changes in treatment practice for patients with newly diagnosed atrial fibrillation during an era when non-vitamin K antagonist oral anticoagulants (NOACs) were becoming more widely adopted. In these analyses, the key factors which determined the choice between NOACs and vitamin K antagonists (VKAs) are explored

    Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Results From the GARFIELD-AF Registry

    No full text
    BACKGROUND: Atrial fibrillation is associated with increased risks of death, stroke/systemic embolism, and bleeding (incurred by antithrombotic therapy), which may occur early after diagnosis
    corecore